Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Academic Partnership Program Funds University of Texas Southwestern Researcher

Published: Wednesday, November 14, 2012
Last Updated: Wednesday, November 14, 2012
Bookmark and Share
AB SCIEX is supporting the lipidomics research of Jeff McDonald, Ph.D., an associate professor in the Department of Molecular Genetics at the University of Texas Southwestern Medical Center.

This is the first grant awarded to an academic researcher as part of the AB SCIEX Academic Partnership Program,  which was launched earlier this year. This grant aims to help Dr. McDonald accelerate advancements toward the realization of personalized medicine.

AB SCIEX selected Dr. McDonald as the program’s first grant winner because of the breakthrough work he is doing to advance lipidomics and metabolomics. Dr. McDonald is a leader in the field of lipidomics, and his work includes directing the mass spectrometry branch of the LIPID MAPS Sterol Core where they recently concluded a sterolomic analysis of the Dallas Heart Study, a 3200+ human subject cohort.

Dr. McDonald has ongoing collaborations with Phil Sanders, a senior research scientist at a leading pharmaceutical company, who pioneered direct infusion techniques using the TripleTOF 5600 platform, which will be the basis for the work at UT Southwestern. With access to extensive collections of biological samples at UT Southwestern, this academic researcher sees an opportunity for significant discoveries. Ultimately, lipidomic and metabolomic analysis of human samples will elucidate new understanding of disease states that will help in the development of treatments of metabolic diseases, such as obesity, hypertension and diabetes.

Prior to the grant from AB SCIEX, the team at UT was limited in what they could achieve in infusion-based lipidomics research and unable to apply the workflows that Sanders had developed. Funding to acquire the instrument had been a major challenge for Dr. McDonald and his team, who have been focused on lipidomics for the past eight years. The answer was AB SCIEX’s program for academics.

“The AB SCIEX Academic Partnership program cleared the way for us to bring on campus the TripleTOF 5600+ system, which is exactly the technology needed by the lipid field to advance the study of lipidomics,” said Jeff McDonald, Associate Professor at the University of Texas Southwestern Medical Center in Dallas. “AB SCIEX instrumentation is second to none, especially the Turbo V ion source, which is tough as nails and allows us to do things that simply cannot be done on other instruments. We wouldn’t have the latest innovations in mass spectrometry at UT Southwestern if not for the company’s academic partnership program. We appreciate and value AB SCIEX’s support for academic research.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
Sciex, Hepregen Team up on Metabolite Identification Offering
This recently announced collaboration aims to provide practical solutions for drug metabolism researchers.
Thursday, May 21, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
Barry Karger Receives Arnold O. Beckman Award
Award honors Prof Karger for his outstanding achievements in the field of electrodriven separation techniques.
Monday, April 28, 2014
Researchers Solve a Mystery about Type 2 Diabetes Drug
AB SCIEX TripleTOF® and QTRAP® technologies support breakthrough medical study.
Friday, November 22, 2013
AB SCIEX Expands Support in the Middle East
AB SCIEX announces the opening of a new regional office and technical support centre located in Dubai.
Tuesday, October 29, 2013
AB SCIEX Receives Frost & Sullivan Award
AB SCIEX has been awarded the 2013 Global Market Share Leadership Award for Mass Spectrometry from Frost & Sullivan.
Thursday, September 12, 2013
AB SCIEX and LECO Announces Co-marketing Agreement
Bundled solutions leverage the synergy between two technology leaders.
Thursday, July 04, 2013
AB SCIEX and UOW to Collaborate
A research partnership between AB SCIEX and the University of Wollongong will develop lipid analysis capabilities, including the most definitive and comprehensive identification of double bond position in lipids.
Friday, September 21, 2012
AB Sciex Agrees for Sigma-Aldrich® to Distribute iChemistry™ Solutions
Broadens availability of mass spectrometry-based tagging chemistries to biologists and chemists worldwide.
Wednesday, September 12, 2012
AB SCIEX and Premier Biosoft Collaborate on Lipidomics Software
PREMIER Biosoft and AB SCIEX collaborate by offering data analysis solutions for lipidomics.
Monday, June 04, 2012
AB SCIEX Announces Academic Partnership Program
The program aims to increase the number of scientists who benefit from the company’s assistance and resources for advancing research in proteomics, metabolomics and lipidomics.
Wednesday, April 04, 2012
AB SCIEX Announces Academic Partnership Program to Support Biological Research
Focus on proteomics, metabolomics and lipidomics to accelerate promising work in science and biomedical studies.
Wednesday, March 28, 2012
AB SCIEX Expands Commercial Operations in Brazil
The expansion will support the increasing use of mass spectrometry for food safety testing, environmental analysis, academic research, drug development, forensic toxicology and clinical research.
Monday, March 19, 2012
Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Some Women With PCOS May Have Adrenal Disorder
Researchers at NIH have found that a subgroup of women with PCOS, a leading cause of infertility, may produce excess adrenal hormones.
Making Metabolite Identification More Efficient
Metasense combines the industry's most-comprehensive metabolic transformation prediction with efficient analysis of LC/MS analytical measurements to identify, visualize, and report chemical biotransformations.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
New Treatment for Pancreatic Cancer
Researchers at Purdue University have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
How Different People Respond To Aspirin
Study findings could be used to help identify those who would benefit most from aspirin use.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!